Clever Leaves Holdings Inc. Stock News

BOCA RATON, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed produ

BOCA RATON, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed prod

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we mak

Eine Liefervereinbarung zwischen den Cannabisanbietern Clever Leaves und FoliuMed ermöglicht den Export von Cannabisextrakten pharmazeutischer Qualität aus Kolumbien nach Deutschland.

Clever Leaves Holdings Inc. (NASDAQ: CLVR ) has signed a one-year international sales agreement with German- Colombian operator FoliuMed Holdings and its German manufacturing partner, Fidelio Healthcare. With access to three of Clever Leaves’ pharmaceutical grade bulk cannabis extracts, Fidelio will be ramping up production using Clever Leaves’ full spectrum THC crude extract, standardized 20% CBD extract, and CBD isolate. With high production standards recognized domestically and abroad, including both Good Manufacturing Practices certification from Colombia and European Union Good Manufacturing Practices certification from Europe, Clever Leaves’ Colombian pharmaceutical-grade cannabis will be utilized by Fidelio’s manufacturing and distribution … Full story available on Benzinga.com

Clever Leaves Holdings Inc. (NASDAQ: CLVR ) has inked a four-year take or pay supply agreement with an Australian medicinal cannabis company, Australian Natural Therapeutics Group. Under the agreement, Clever Leaves will supply CBD isolate and GMP certified THC crude oil from its operation in Colombia and THC dried flower from its GACP- certified operation in Portugal. In addition, A NTG has committed to purchasing a minimum of $7.8M worth of product , with the next shipment planned for … Full story available on Benzinga.com

Clever Leaves Holdings Inc. (NASDAQ:CLVR) has inke…

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we mak

Clever Leaves (CLVR) signed a 4-year take or pay supply agreement with medicinal cannabis firm Australian Natural Therapeutics Group (ANTG).CLVR will supply CBD isolate and…

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we mak

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ:

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR ) will soon be available for distribution by its partner in Germany , Ethypharm GmbH , a European specialty pharmaceutical company. Following a March 2021 supply agreement signed by the two companies providing Ethypharm access to Clever Leaves Holdings EU GMP certified cannabis extracts , the shipment includes two products: a 100 mg CBD with 3 mg THC per gram formulation and a 200 mg CBD with 6 mg THC per gram formulation . “As the largest medical cannabis market in Europe and one of the most … Full story available on Benzinga.com

Products imported and to be commercially available in German pharmacies Products imported and to be commercially available in German pharmacies

Produkte sind bald in deutschen Apotheken erhältlich Produkte sind bald in deutschen Apotheken erhältlich

Products imported and to be commercially available in German pharmacies Products imported and to be commercially available in German pharmacies